Gene: RAB19
Official Full Name: RAB19, member RAS oncogene familyprovided by HGNC
Gene Summary: Predicted to enable GTPase activity. Predicted to be involved in autophagosome assembly and intracellular protein transport. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21361 | RAB19 Knockout cell line (HCT 116) | Human | RAB19 | 1:2~1:4 | Negative | Online Inquiry |
RAB19 Gene Knockout Cell Lines are specialized cell models engineered to eliminate the expression of the RAB19 gene, a member of the RAB GTPase family that plays a crucial role in intracellular membrane trafficking and vesicle dynamics. By specifically targeting and knocking out RAB19, these cell lines allow researchers to investigate the gene’s functional role in cellular processes, including endocytosis, exocytosis, and the modulation of signaling pathways critical for cell survival and proliferation.
The mechanism of action hinges on CRISPR/Cas9 technology, which enables precise editing capabilities to induce double-strand breaks at the RAB19 locus. The resulting cell lines are invaluable tools for examining the consequences of RAB19 loss on cellular behavior, including alterations in growth patterns, sensitivity to chemotherapeutics, and impacts on cellular communication. This capability is particularly significant in the context of studying various disease models, where dysregulation of RAB proteins is implicated.
The scientific importance of RAB19 Gene Knockout Cell Lines extends to diverse applications in both basic and applied research settings. They provide insights into cellular architecture and may reveal novel targets for therapeutic intervention, especially in cancer and neurodegenerative diseases. Additionally, these knockout lines can serve as valuable controls in experiments involving RAB19-related pathways.
In comparison to traditional knockout methodologies, our RAB19 Gene Knockout Cell Lines offer a streamlined approach with high efficiency and reproducibility. Unlike conventional methods, which can introduce off-target effects or require extensive time for validation, our CRISPR-engineered lines ensure specificity and allow for immediate application in experimental setups.
For researchers and clinicians seeking to deepen their understanding of intracellular dynamics or explore innovative treatment strategies, RAB19 Gene Knockout Cell Lines present a distinguished advantage as a reliable and precise solution. They not only enhance the capability for pioneering discoveries but also facilitate translational research that can lead to real-world clinical applications.
As a leader in the biotech industry, our company brings together cutting-edge technology and expertise in gene editing to provide researchers with the highest quality biological products, ensuring you have the tools necessary for advancing your work in cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.